Story thread · 2 reports / 2 sources

FDA gains ‘continuity’ as Mikhail, Davis named permanent CBER, CDER leaders

biopharmadive.com · 5dShare

After almost two years of turnover in the FDA’s top ranks, the new appointments should help ease concerns about more turmoil ahead, one analyst said.

First report: Current heads of CBER, CDER snag permanent jobs — endpts.com, 6d